Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Gastrointestinal cancer

Daily Vigorous Intensity Physical Activity and Its Preventive Effect on Pancreatic Cancer

Sung Keun Park, Ju Young Jung, Chang-Mo Oh, Min-Ho Kim, Eunhee Ha, Yeji Kim, Do Jin Nam, Jae-Hong Ryoo

Cancer Res Treat. 2022;54(3):873-881. Published online September 27, 2021 DOI: https://doi.org/10.4143/crt.2021.400

Cited By 1

First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017

Mee Joo Kang, Jiwon Lim, Sung-Sik Han, Hyeong Min Park, Sang-Jae Park, Young-Joo Won, Sun-Whe Kim

Cancer Res Treat. 2022;54(1):208-217. Published online May 21, 2021 DOI: https://doi.org/10.4143/crt.2021.421

Cited By 5

Gastrointestinal Cancer

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer

Kyung-Hun Lee, Eui Kyu Chie, Seock-Ah Im, Jee Hyun Kim, Jihyun Kwon, Sae-Won Han, Do-Youn Oh, Jin-Young Jang, Jae-Sung Kim, Tae-You Kim, Yung-Jue Bang, Sun Whe Kim, Sung W. Ha

Cancer Res Treat. 2021;53(4):1096-1103. Published online December 30, 2020 DOI: https://doi.org/10.4143/crt.2020.928

Cited By 5

Gastrointestinal cancer

Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer

Lin Fang, Fei-Hu Yan, Chao Liu, Jing Chen, Dan Wang, Chun-Hui Zhang, Chang-Jie Lou, Jie Lian, Yang Yao, Bo-Jun Wang, Rui-Yang Li, Shu-Ling Han, Yi-Bing Bai, Jia-Ni Yang, Zhi-Wei Li, Yan-Qiao Zhang

Cancer Res Treat. 2021;53(1):131-139. Published online August 24, 2020 DOI: https://doi.org/10.4143/crt.2020.330

Cited By 20

Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, Inhwan Hwang, Jae Ho Jeong, Heung-Moon Chang, Dongwook Oh, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Kyu-pyo Kim, Baek-Yeol Ryoo

Cancer Res Treat. 2020;52(1):254-262. Published online July 9, 2019 DOI: https://doi.org/10.4143/crt.2019.190

Cited By 12

Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer

Mei Hua Jin, Ah-Rong Nam, Ji Eun Park, Ju-Hee Bang, Yung-Jue Bang, Do-Youn Oh

Cancer Res Treat. 2020;52(1):149-166. Published online June 25, 2019 DOI: https://doi.org/10.4143/crt.2019.183

Cited By 25

The Role of Consolidation Chemoradiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Systematic Review and Meta-Analysis

Jeffrey S. Chang, Yen-Feng Chiu, Jih-Chang Yu, Li-Tzong Chen, Hui-Ju Ch’ang

Cancer Res Treat. 2018;50(2):562-574. Published online June 9, 2017 DOI: https://doi.org/10.4143/crt.2017.105

Cited By 12

Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost–Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study

Sang Myung Woo, Min Kyeong Kim, Jungnam Joo, Kyong-Ah Yoon, Boram Park, Sang-Jae Park, Sung-Sik Han, Ju Hee Lee, Eun Kyung Hong, Yun-Hee Kim, Hae Moon, Sun-Young Kong, Tae Hyun Kim, Woo Jin Lee

Cancer Res Treat. 2017;49(4):1022-1032. Published online January 19, 2017 DOI: https://doi.org/10.4143/crt.2016.495

Cited By 8

Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis

Kyung Su Kim, Jeanny Kwon, Kyubo Kim, Eui Kyu Chie

Cancer Res Treat. 2017;49(3):824-833. Published online August 26, 2016 DOI: https://doi.org/10.4143/crt.2016.336

Cited By 53

Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen

Changhoon Yoo, Bum Jun Kim, Kyu-pyo Kim, Jae-Lyun Lee, Tae Won Kim, Baek-Yeol Ryoo, Heung-Moon Chang

Cancer Res Treat. 2017;49(3):759-765. Published online November 9, 2016 DOI: https://doi.org/10.4143/crt.2016.371

Cited By 26

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy

Inkeun Park, Seung Joon Choi, Young Saing Kim, Hee Kyung Ahn, Junshik Hong, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Jae Hoon Lee, Yong Ju Shin, Dong Bok Shin

Cancer Res Treat. 2016;48(4):1264-1273. Published online March 23, 2016 DOI: https://doi.org/10.4143/crt.2015.250

Cited By 35

Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma

Hyung Soon Park, Hye Sun Lee, Ji Soo Park, Joon Seong Park, Dong Ki Lee, Se-Joon Lee, Dong Sup Yoon, Min Goo Lee, Hei-Cheul Jeung

Cancer Res Treat. 2016;48(4):1253-1263. Published online February 3, 2016 DOI: https://doi.org/10.4143/crt.2015.400

Cited By 16

Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer

Marcin R. Lener, Rodney J. Scott, Anna Wiechowska-Kozłowska, Pablo Serrano-Fernández, Piotr Baszuk, Katarzyna Jaworska-Bieniek, Grzegorz Sukiennicki, Wojciech Marciniak, Magdalena Muszyńska, Józef Kładny, Tomasz Gromowski, Katarzyna Kaczmarek, Anna Jakubowska, Jan Lubiński

Cancer Res Treat. 2016;48(3):1056-1064. Published online December 28, 2015 DOI: https://doi.org/10.4143/crt.2015.282

Cited By 44

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study

Younak Choi, Do-Youn Oh, Kyubo Kim, Eui Kyu Chie, Tae-Yong Kim, Kyung-Hun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Sung Whan Ha, Yung-Jue Bang

Cancer Res Treat. 2016;48(3):1045-1055. Published online October 16, 2015 DOI: https://doi.org/10.4143/crt.2015.226

Cited By 9

The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy

Younak Choi, Tae-Yong Kim, Do-Youn Oh, Kyung-Hun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang

Cancer Res Treat. 2016;48(1):171-179. Published online March 13, 2015 DOI: https://doi.org/10.4143/crt.2014.292

Cited By 49

p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines

Sung-Ung Moon, Jin Won Kim, Ji Hea Sung, Mi Hyun Kang, Se-Hyun Kim, Hyun Chang, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee

Cancer Res Treat. 2015;47(3):501-508. Published online November 24, 2014 DOI: https://doi.org/10.4143/crt.2014.054

Cited By 23

Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma

Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jin-Young Jang, Sun Whe Kim, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Ijin Joo, Sung W. Ha

Cancer Res Treat. 2015;47(2):274-281. Published online September 12, 2014 DOI: https://doi.org/10.4143/crt.2014.025

Cited By 5

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer

Jae Yun Lim, Jang Ho Cho, Se Joon Lee, Dong Ki Lee, Dong Sup Yoon, Jae Yong Cho

Cancer Res Treat. 2015;47(2):266-273. Published online August 29, 2014 DOI: https://doi.org/10.4143/crt.2013.158

Cited By 5

p27 Loss Is Associated with Poor Prognosis in Gastroenteropancreatic Neuroendocrine Tumors

Hee Sung Kim, Hye Seung Lee, Kyung Han Nam, Jiwoon Choi, Woo Ho Kim

Cancer Res Treat. 2014;46(4):383-392. Published online July 17, 2014 DOI: https://doi.org/10.4143/crt.2013.102

Cited By 20

A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer

Jong Gwon Choi, Jae Hong Seo, Sang Cheul Oh, Chul Won Choi, Jun Suk Kim

Cancer Res Treat. 2012;44(2):127-132. Published online June 30, 2012 DOI: https://doi.org/10.4143/crt.2012.44.2.127

Cited By 9

Tumor Angiogenesis: Initiation and Targeting - Therapeutic Targeting of an FGF-Binding Protein, an Angiogenic Switch Molecule, and Indicator of Early Stages of Gastrointestinal Adenocarcinomas -

Elena Tassi, Anton Wellstein

Cancer Res Treat. 2006;38(4):189-197. Published online December 31, 2006 DOI: https://doi.org/10.4143/crt.2006.38.4.189

Cited By 17

Identification of CLP36 as a Tumor Antigen that Induces an Antibody Response in Pancreatic Cancer

Su-Hyung Hong

Cancer Res Treat. 2005;37(1):71-77. Published online February 28, 2005 DOI: https://doi.org/10.4143/crt.2005.37.1.71

Cited By 5

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX

So Heun Lee, Dae Wook Hwang, Changhoon Yoo, Kyo-pyo Kim, Sora Kang, Jae Ho Jeong, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Yejong Park, Bong Jun Kwak, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim

Received June 26, 2022 Accepted February 20, 2023 Published online February 27, 2023
DOI: https://doi.org/10.4143/crt.2022.409
[Accepted]